| Chelsea R Gomer, CNP | |
|
3015 3rd Ave Se, Aberdeen, SD 57401-5418 | |
| (605) 226-5500 | |
| Not Available |
| Full Name | Chelsea R Gomer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 3015 3rd Ave Se, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407309057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | CP001099 (South Dakota) | Secondary |
| 363LX0001X | Nurse Practitioner - Obstetrics & Gynecology | CP001099 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Aberdeen | Aberdeen, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Health Network | 6800707100 | 272 |
News Archive
To prevent medical mishaps with patients caused by telephone communication failures, researchers at Yale School of Medicine and the VA Connecticut Healthcare System report in the October issue of Journal of General Internal Medicine that expanded physician and residency training in telephone medicine is needed.
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.
SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis
Governments could add thousands of millions of dollars to the global economy simply by investing in eye examinations and the provision of glasses for some 703 million people who need them, according to a study published this month in the Bulletin of the World Health Organization.
Investigators from the Institute for Research in Immunology and Cancer at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the first of its kind, which allows for the multiplication of stem cells in a unit of cord blood.
› Verified 8 days ago
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790721280 PECOS PAC ID: 6800707100 Enrollment ID: O20031111000266 |
News Archive
To prevent medical mishaps with patients caused by telephone communication failures, researchers at Yale School of Medicine and the VA Connecticut Healthcare System report in the October issue of Journal of General Internal Medicine that expanded physician and residency training in telephone medicine is needed.
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.
SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis
Governments could add thousands of millions of dollars to the global economy simply by investing in eye examinations and the provision of glasses for some 703 million people who need them, according to a study published this month in the Bulletin of the World Health Organization.
Investigators from the Institute for Research in Immunology and Cancer at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the first of its kind, which allows for the multiplication of stem cells in a unit of cord blood.
› Verified 8 days ago
| Entity Name | Avera St Lukes |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215100813 PECOS PAC ID: 6406764927 Enrollment ID: O20040120000912 |
News Archive
To prevent medical mishaps with patients caused by telephone communication failures, researchers at Yale School of Medicine and the VA Connecticut Healthcare System report in the October issue of Journal of General Internal Medicine that expanded physician and residency training in telephone medicine is needed.
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.
SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis
Governments could add thousands of millions of dollars to the global economy simply by investing in eye examinations and the provision of glasses for some 703 million people who need them, according to a study published this month in the Bulletin of the World Health Organization.
Investigators from the Institute for Research in Immunology and Cancer at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the first of its kind, which allows for the multiplication of stem cells in a unit of cord blood.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea R Gomer, CNP Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Chelsea R Gomer, CNP 3015 3rd Ave Se, Aberdeen, SD 57401-5418 Ph: (605) 226-5500 |
News Archive
To prevent medical mishaps with patients caused by telephone communication failures, researchers at Yale School of Medicine and the VA Connecticut Healthcare System report in the October issue of Journal of General Internal Medicine that expanded physician and residency training in telephone medicine is needed.
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.
SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis
Governments could add thousands of millions of dollars to the global economy simply by investing in eye examinations and the provision of glasses for some 703 million people who need them, according to a study published this month in the Bulletin of the World Health Organization.
Investigators from the Institute for Research in Immunology and Cancer at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the first of its kind, which allows for the multiplication of stem cells in a unit of cord blood.
› Verified 8 days ago
Ashley Marie Landis, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 8th Ave Nw, Suite A, Aberdeen, SD 57401 Phone: 605-226-2663 | |
Lindsay Habeck, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3015 3rd Ave Se, Aberdeen, SD 57401 Phone: 605-226-5500 | |
Matthew R Lutjens, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 S State St Ste 113, Aberdeen, SD 57401 Phone: 605-225-0378 Fax: 605-225-7919 | |
Ms. Valerie Anne Jones, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1315 6th Ave Se, Suite 6, Aberdeen, SD 57401 Phone: 605-225-1538 Fax: 605-229-2053 | |
Kristine Lynn Fastenau, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 310 S Penn St Ste 203, Aberdeen, SD 57401 Phone: 605-225-7326 | |
Alisa Hogue, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 310 S Penn St, Suite 202, Aberdeen, SD 57401 Phone: 605-622-2895 Fax: 605-622-2896 | |
Sara Hegg, CNP, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2120 8th Ave Ne, Aberdeen, SD 57401 Phone: 605-725-4772 Fax: 605-725-4777 |